The phosphorylated derivatives of phosphatidylinositol (PtdIns), known as the polyphosphoinositides (PIs), represent key membranelocalized signals in the regulation of fundamental cell processes, such as membrane traffic and cytoskeleton remodelling. The reversible production of the PIs is catalyzed through the combined activities of a number of specific phosphoinositide phosphatases and kinases that can either act separately or in concert on all the possible combinations of the 3, 4, and 5 positions of the inositol ring. So far, seven distinct PI species have been identified in mammalian cells and named according to their site(s) of phosphorylation: PtdIns 3-phosphate (PI3P); PtdIns 4-phosphate (PI4P); PtdIns 5-phosphate (PI5P); PtdIns 3,4-bisphosphate (PI3,4P2); PtdIns 4,5-bisphosphate (PI4,5P2); PtdIns 3,5-bisphosphate (PI3,5P2); and PtdIns 3,4,5-trisphosphate (PI3,4,5P3). Over the last decade, accumulating evidence has indicated that the different PIs serve not only as intermediates in the synthesis of the higher phosphorylated phosphoinositides, but also as regulators of different protein targets in their own right. These regulatory actions are mediated through the direct binding of their protein targets. In this way, the PIs can control the subcellular localization and activation of their various effectors, and thus execute a variety of cellular responses. To exert these functions, the metabolism of the PIs has to be finely regulated both in time and space, and this is achieved by controlling the subcellular distribution, regulation, and activation states of the enzymes involved in their synthesis and removal (kinases and phosphatases). These exist in many different isoforms, each of which appears to have a distinctive intracellular localization and regulation. As a consequence of this subcompartimentalized PI metabolism, a sort of ''PI-fingerprint'' of each cell membrane compartment is generated. When combined with the targeted recruitment of their protein effectors and the different intracellular distributions of other lipids and regulatory proteins (such as small GTPases), these factors can maintain and determine the identity of the cell organelles despite the extensive membrane flux [S. Munro, Organelle identity and the organization of membrane traffic, Nat. Cell. Biol. 6 (2004) 469 -4721]. Here, we provide an overview of the regulation and roles of different phosphoinositide kinases and phosphatases and their lipid products at the Golgi complex. D
The phosphoinositide kinases
The Golgi complex (GC) possesses many phosphoinositide kinases (PIKs): the phosphoinositide 3-kinases (PI3Ks), the phosphoinositide 4-kinases (PI4Ks), and the phosphoinositide phosphate (PIP) 5-kinases (PIP5Ks).
The PI3Ks can be assigned to three separate classes (I, II, III) based on their domain structures, differences in catalytic activities towards distinct substrates, and modes of regulation [2] . The class I PI3Ks are further subdivided into two classes: IA and IB. The prototypical class IA PI3Ks are composed of a catalytic p110 subunit and a regulatory subunit. A number of distinct regulatory subunits (50 to 85 kDa) and p110 subunits (p110a, p110h, and p110y) have been identified. The single class IB PI3K is made up of a p110 catalytic subunit and a p101 regulatory subunit. In vitro, class I PI3Ks can phosphorylate PtdIns, PI4P, and PI4,5P2, although it is very well established that the intracellular product of these kinases is mainly PI3,4,5P3. The class II PI3Ks (a, h, and g) are larger molecules that, in vitro, catalyze the phosphorylation of PtdIns and PI4P, but not of PI4,5P2. The class III PI3Ks are represented by the 0167 Among the different PI3Ks, only two isoforms of the class II PI3Ks, PI3KIIa and PI3KIIg, have been shown to be associated with the GC [3] [4] [5] . Moreover, PI3KIIa can bind clathrin, and it is stimulated by this interaction. The overexpression of this kinase induces the redistribution of the mannose 6-phosphate receptor (M6PR) from the transGolgi network (TGN) to the cell periphery and inhibits endocytosis [3] . Thus, PI3KIIa might control clathrindependent sorting events at the TGN through a localized generation of PI3P at sites of clathrin-coated bud formation (see below).
The PI4Ks catalyze the phosphorylation of PtdIns on the D-4 position of the inositol ring, and these enzymes can only phosphorylate PtdIns. This thus generates PI4P, which is the major precursor in the synthesis of the other PIs, including PI4,5P2, PI3,4P2 and PI3,4,5P3. Two types of PI4Ks (types II and III) have been identified in mammalian cells and in the yeast Saccharomyces cerevisiae based on their biochemical properties. The mammalian type II PI4Ks (PI4KIIs) comprise two isoforms, PI4KIIa and PI4KIIh. These two enzymes are very similar to each other, but they lack the characteristic catalytic kinase domain found in PI3K and type III PI4K. The yeast orthologue of PI4KII is the LSB6 gene product [6] , which is a non-essential gene and which accounts for a minor fraction of total PI4K activity in yeast. PI4KII is tightly associated to membranes and localizes to the GC and the endocytic compartment. PI4KIIh is mostly cytosolic, and it is recruited to membranes and activated by Rac1 [7] .
Two isoforms of PI4KIII have been cloned in mammalian cells: a 220 kDa a form, which is the homologue of the yeast PI4K stt4p, and a 110 kDa h form, which is the mammalian orthologue of the yeast Pik1p [8] . PI4KIIa has been found at the plasma membrane and on the endoplasmic reticulum (ER; [9] ). PI4KIIh is among the best studied of the GC PIKs in terms of its regulation (see below), and in agreement with its yeast homologue Pik1p, it is required for the structural integrity of the GC and the regulation of protein transport from the GC to the plasma membrane [10] , and also of that through the GC in polarized cells [11] .
The PIP5Ks were originally identified as activities that can phosphorylate PI4P to generate PI4,5P2. Two different classes of PIP5Ks have been classified based on their sensitivities to phosphatidic acid (PA); type I PIP5Ks are stimulated by PA, while type II PIP5Ks are not [12, 13] . However, it was later realized that these type II kinases phosphorylate the 4-position and not the 5-position of the inositol ring, and thus, these are PIP4Ks that use PI3P and PI5P and produce PI3,4P2 and PI4,5P2, respectively [14] .
A broad in vitro substrate specificity has also been reported for type I PIP5K, which produces PI3,5P2 and PI3,4,5P3 from PI3P and PI3,4P2, respectively [2] . To date, three isoforms (a, h, and g of both mammalian Type I and Type II PIP5Ks) have been cloned. These two classes of PIP5Ks appear to be functionally non-redundant despite the fact that they synthesise the same product, PI4,5P2. The type I PIP5Ks are found at the plasma membrane and in the nucleus, whereas the type II PIPKs localize to the cytosol, the ER, the nucleus, and the actin skeleton, but not at the plasma membrane [2] .
S. cerevisiae has only one PIP5K, Mss4p, which is related to the mammalian type I class of enzymes. Yeast also possess a PI5K, Fab1p, which phosphorylates PI3P to produce PI3,5P2. The mammalian orthologue of this enzyme is PIKfyve, which, in vitro, can phosphorylate PtdIns and PI3P to generate PI5P and PI3,5P2, respectively. PIKfyve resides in the late endocytic compartment [15, 16] . However, a subfraction of PIKfyve has been shown to associate with GC membranes. Recent studies using the expression of a kinase-dead PIKfyve and the microinjection of specific PIKfyve antibodies have demonstrated, however, that its main role is in the control of fluid-phase endocytosis and in the regulation of the biogenesis of multivesicular bodies (MVBs; [15 -17] ).
None of the known PIP5K isoforms have been visualized at the GC, although there is evidence indicating that a PIP5K activity associates with the GC membranes upon the activation of the small GTPase Arf [10] , and that its product, PI4,5P2, has a role in many traffic steps at the GC, including ER-to-Golgi transport, the formation of post-Golgi transport carriers and of secretory granules, and the maintenance of the structure of the GC itself [18] .
The polyphosphoinositide phosphatases
The PI phosphatases are generally included in four categories according to their ability to hydrolyze the 3-, 4-, or 5-phosphorylated inositol phosphates or PIs (see Fig. 1 and Table 1 ). Compared to the kinases discussed above, the PI phosphatases at the GC are less well characterized in terms of their regulation and their contributions to the PI balance and to the function/structure of the GC.
The PI3-phosphatases comprise the tumour suppressor PTEN (phosphatase and tensin homologue) and its related proteins (TPIE, transmembrane phosphatase with tensin homology, and TPIP, TPTE-and PTEN-homologous inositol lipid phosphatase) and myotubularin (MTM) and myotubularin-related proteins (MTMRs). The best described substrate of PTEN is PI3,4,5P3, while the lipid substrate specificity for MTM1 and the MTMRs is PI3P. TPTE is a testis-specific transmembrane protein that is localized at the plasma membrane and that appears to lack detectable PI3-phosphatase activity due to two amino acid substitutions in the active site of the phosphatase. A protein that is likely to be the murine orthologue of TPTE (termed mPTEN) has also been seen to be testis specific; it is active as a PI3-phosphatase and localized to the GC [19, 20] .
The PI4-phosphatases include two classes, type I and type II, which use PI3,4P2 as their preferred substrate. These have no significant homologues in the S. cerevisiae genome. However, a PI4-phosphatase activity has also been shown to be associated with the Sac phosphatase domain, which is present in different proteins, both in yeast and mammals [21] .
Proteins that contain the Sac phosphatase domain can be divided into two groups: The first includes the PIP5- [21, 22] . Yeast SAC1 mutants show greater increase in their PI4P levels as compared to those of PI3,5P2 and PI3P, suggesting that PI4P is the preferred substrate in vivo. At the same time, yeast SAC1 mutants can show a wide array of phenotypes, including inositol auxotrophy, secretory defects, impaired ATP transport into the ER, and disorganization of the actin cytoskeleton. Sac1p localizes to the ER and the GC. Recently, it has been shown that the dolicholphosphate mannose synthase Dpm1p is responsible for the ER localization of Sac1p when cells undergo rapid proliferation [23] . A starvation-induced shut-down of cell growth is associated with a fast and reversible translocation of Sac1p to the GC [23] . This suggests that by controlling the level of PI4P in different organelles, Sac1p is able to synchronize the secretory capacity of the ER and GC under different growth conditions. Indeed, PI4P depletion has been shown to inhibit anterograde transport from the GC to the plasma membrane [24, 25] , while its accumulation in the ER leads to a reduction in the secretory-protein processing of the ER and an accumulation of ER membranes [26, 27] . The human homologue of Sac1p, hSac1, behaves as the yeast isoform in terms of its substrate specificity and localization [28] . Recently, it has been shown that hSac1 can interact with COPI, as the mutation of a putative COPIinteracting motif (KXKXX) abolishes this interaction and results in the accumulation of hSac1 in the GC. However, the function of hSac1 within the ER and the GC remains to be determined [28] .
The inositol polyphosphate 5-phosphatases are a large family of proteins that hydrolyze the 5-phosphate from the inositol ring of both the inositol phosphates and/or the PIs. Different PI5-phosphatases are localized at the GC, including OCRL-1 and the 75-kDa 5-phosphatase pharbin [29, 30] . However, their functional roles and their regulation here are largely unknown.
Mutation in the OCRL gene causes a severe disease, known as Lowe syndrome (or OCRL; [30] ). This is a rare, X-linked disorder that is characterized by congenital cataracts, mental retardation, and renal ion transport defects (Fanconi's syndrome). Kidney proximal tubule cells from OCRL patients have elevated levels of PI4,5P2. Ocrl-1 knock-out mice do not, however, develop the symptoms present in OCRL, presumably because of a functional overlap between Ocrl-1 and other PI5-phosphatases [31] . Ocrl-1 is localized at the GC in fibroblasts and epithelial cells [32] , although its presence in lysosomes in normal human kidney cells has also been reported [33] . Recent data indicate, however, that Ocrl-1 is primarily localized in the endosomal system and at the TGN [34] and that Ocrl-1 may interact with the AP-2 adaptor and the clathrin coat, which are involved in endocytosis.
Regulators of phosphoinositide metabolism at the Golgi complex
The GC thus hosts a vast array of PIKs and PI phosphatases. But how are the activities and locations of these enzymes regulated? In other words, what are the factors that drive their targeting and that affect the balance between the activities of the kinases and phosphatases, thus determining the actual concentrations of the different PI species at the GC?
One important factor here is substrate availability/ accessibility. The availability of the ''parental'' lipid, PtdIns, is regulated by the PtdIns-transfer proteins (PITPs). In vitro, all of the PITPs stimulate lipid kinase activities: PI4P and PI3P production are increased in in vitro assays with PIKs and PtdIns, regardless of the PITP isoform included or the lipid kinase used [35] . Thus, the specificities of action in vivo appear to be determined by the co-localization of the appropriate lipid kinases and PITPs.
Sec14p, the major yeast PITP, is essential for cell viability and regulates the budding of secretory vesicles from a late GC compartment [36] .
Due to its ability to bind both PtdIns and phosphatidylcholine (PtdCho), PITP has the possibility of regulating two fundamental lipid metabolic pathways in yeast -PtdIns synthesis and PtdCho synthesis, by promoting PI4P and PI4,5P2 generation and inhibiting PtdCho synthesis via the CDP -choline pathway (a potent consumer of diacylglycerol [DAG] ). Despite the lack of consensus as to which of these different metabolic disruptions caused by SEC14 ablation has the major impact on the secretory pathway, it is certain that both DAG and PI4P are critical in the regulation of Sec14p-dependent GC secretory function [36] . In particular, the overexpression of the yeast PI4K Pik1p is able to rescue some of the secretory defects present in Sec14-temperature-sensitive strains [25, 37] . Mammalian cells express three Sec14p orthologues: PITPa PITPh, and RdgB/Nir2; the last two of these, PITPh and RdgB/Nir2, are localized at the GC [38, 39] . PITP activity has also been shown to be required in regulated exocytosis, in intra-Golgi transport, and in the biogenesis of secretory granules and vesicles at the TGN [40, 41] . RdgB/Nir2 itself can directly interact with a PI4KIIIa, as it has been shown that a truncated RdgB/Nir2 mutant that interacts with PI4KIIIa, but that does not localize to the GC, is unable to produce PI4P in the absence of exogenous PtdIns [38] . Similarly, it has been proposed that RdgB/Nir2-dependent PI4P production requires both its interaction with PI4KIIIa and its localization at the GC, and it has very recently been shown that RdgB/Nir2 is required for TGN-to-plasma membrane transport [42] .
As there are no known cytosolic proteins able to transfer the PIs themselves, this thus indicates that the factors that control the access of the PIP kinases and PI phosphatases to their substrates include the transport of PIs during bulk membrane flow and PI-binding proteins that associate with the PIs through their specific recognition and binding domains (see below and Fig. 1) . Thus, the PI-binding proteins may be viewed not only as PI targets, but also as regulators of the accessibility of ''their'' PI for other proteins with which they share the same PI ligand specificity and intracellular localization.
Another important clue in the regulation of PI metabolism is the proper targeting of the PI-modifying enzymes. In fact, the majority of these are cytosolic proteins that undergo a membrane/cytosol shuttling. In many cases, this is under the control of the small GTPases belonging to the Arf, Rab, and Rho families. In other cases, this includes components of the core machineries responsible for the membrane transport processes (i.e., clathrin [3, 34] and COPI [28] ) that are able to interact with PIKs (e.g., PI3KIIa [3] ) or PI phosphatases (e.g., Ocrl-1 [34] and Sac1 [28] ), and can thus recruit these selected enzyme activities to very specific sites.
Finally, the catalytic activities of the enzymes themselves can be differently modulated. This level of modulation can be operated either by PIK or PI phosphatase interactors that may also act as their recruiters (i.e., Arf for PI4KIIIh [10] ) or by interactors that apparently do not intervene in the recruiting process (i.e., beclin for PI3K; [43] ). Similarly, these activities can also be modulated by second messengers (i.e., calcium) or by autophosphorylation or heterophosphorylation, as seen in the case of vps15, which phosphorylates the PI3K vps34 [44] (and possibly protein kinase D that is associated with PI4KII and PIP5K [45] ).
In terms of their regulation, the GC-associated PI4KIIIh is perhaps the best known example. Here, PI4KIIIh is recruited to the GC membranes by the small GTPase Arf1, and Arf1 has been seen to associate directly with PI4KIIIh in a nucleotide-dependent manner [46] . In addition, Burgoyne and colleagues showed that the in vitro translated Arf was able to activate in vitro translated PI4KIIIh, although others who used the same recombinant proteins expressed in Escherichia coli were unable to demonstrate any effect of the addition of Arf1 on the enzymatic activity of PI4KIIIh [47] . This interaction between Arf1 and PI4KIIIh is probably a feature that is conserved in yeast, since a synthetic lethality has been reported for Pik1p and Arf1 and Arf1 accessory proteins, such as ArfGEFs [25] . In addition to Arf1, PI4KIIIh can interact with a second small GTPase, Rab11 [48] . The inhibition of Rab11 binding to PI4KIIIh abolishes the localization of Rab11 to the GC and significantly inhibits transport from the GC to the plasma membrane, suggesting that, in this case, it is the kinase that should be acting as a recruiter for the small GTPase. Interestingly, an interaction between Pik1p with the yeast homologue of Rab11, Ypt31p, has been shown to be important for protein trafficking through the secretory pathway [49] . In this case, it was also proposed that multiple stage-specific signals, which may include Pik1p/ PI4P, act on Ypt31p signalling to regulate the secretory function of the GC.
In yeast, Pik1p is found tightly bound to the Ca 2+ -binding protein frequenin (Frq1p). The association between Frq1p and Pik1p in the absence of calcium is so tight that Frq1p has been considered as a non-catalytic subunit of the enzyme [50] . Pik1p overexpression rescues defects of Frq1p, implying that Pik1p is the sole essential target of Frq1p. At the same time, Frq1p stimulates Pik1p activity, perhaps by displacing an autoinhibitory domain; additionally, Ca 2+ -dependent extrusion of the Frq1p N-myristoyl group may enhance the subcellular targeting of Pik1p [51] . Similarly, in the mammalian system, PI4KIIIh has been reported to associate with the frequenin analogue NCS-1, which is thought to recruit PI4KIIIh to the TGN [52] . The overexpression of NCS-1 and the subsequent activation of PI4KIIIh have also been shown to enhance regulated secretion from PC12 cells in a Ca 2+ -dependent fashion [53] .
Recent data indicate that Arf1 can interact with NCS-1 in a Ca 2+ -dependent and nucleotide-independent manner, and that Arf1 and NCS-1 negatively regulate each other in terms of PI4KIIIh activation, thus suggesting that Arf1 and NCS-1 can, in combination, regulate selective sorting/trafficking events at the TGN, each of which is, however, under the control of PI4KIIIh.
Finally, it has recently been shown that there is synthetic lethality between Pik1p and the 14-3-3 yeast homologue proteins, bmsh1p and bmsh2p (Christiane Walch-Solimena, personal communication).
The polyphosphoinositide targets at the Golgi complex
Over the last decade, a large number of specific PIbinding protein modules have been identified, including the PH, FYVE, PX, ENTH, and ANTH domains (see Fig. 1 ). For an exhaustive treatment of the structures, lipid specificities, and characteristics of these PI-binding modules, we refer the reader to recent reviews [54] . Here, we will focus on the PI-binding proteins that have been found to be localized and/or have a role at the GC (see Fig. 2 ) and on those PI-binding protein modules that have been used as probes to ''visualize'' the PI content of the GC.
The 3-phosphorylated polyphosphoinositides
Of the four 3-phosphorylated PIs, the more represented in resting cells is PI3P, which has been shown to have a pivotal role in the endocytic compartment. Proteins that regulate endocytosis and endosomal trafficking have been shown to contain the two main types of domains that specifically recognize PI3P, the FYVE and PX domains.
When expressed as GFP chimeras, the FYVE domain PI3P-binding modules localize to early endosomes and internal vesicles of MVBs [55] , and the PI3,4P2-binding domains localize to the ER and MVBs as well as the plasma membrane. In contrast, the PI3,4,5P3-specific PH domains are mainly cytosolic in quiescent cells, and they translocate to the plasma membrane in response to stimuli that activate the PI3Ks [18] . However, few of the proteins possessing PI3P-binding modules have been shown to localize at the GC; this would suggest a potential role for this lipid and its effectors in this organelle, although in many cases, this does not appear to be their exclusive localization. Indeed, a large body of evidence obtained in yeast has shown that PI3P regulates membrane trafficking from the GC to the lysosomal compartment, although in mammals, there is currently no conclusive evidence that PI3P has a direct role in membrane traffic at the GC.
Recently, two proteins that specifically interact with PI3P have been found to be required for endosome-to-TGN transport of the M6PR: Sorting nexin 1 (SNX1) and WIPI49 (WD40 repeat protein interacting with PIs; 49 kDa; [56, 57] ). In addition to the PX domain responsible for the PI3P binding, SNX1 possesses a carboxyl terminal BAR (Bin-Amphiphysin-Rvs) domain, which confers to the protein the ability to dimerize and to sense membrane curvature and drive membrane tubulation. Thus, the targeting of SNX1 to endosomal microdomains characterized by the presence of PI3P and high membrane curvature is due to both the PX and the BAR domains. On these membranes, SNX1 regulates tubule-based endosome-to-TGN transport of M6PR [56] . WIPI49 binds to PI3P and, to a lesser extent, to PI3,5P2 and PI5P, and it localizes to the TGN, endosomal membranes, and clathrin-coated vesicles [57] in a phosphoinositide-dependent manner, since treatment with wortmannin leads to a rapid loss of WIPI49 membrane localization. The overexpression of WIPI49 causes a mislocalization of the M6PR and of the g-adaptin subunit of AP-1 from the cell periphery to the perinuclear region, while a knock-down of WIPI49 changes the structure and composition of the early endosomal compartment, suggesting that WIPI49 acts as a PI-sensitive regulatory component of the M6PR pathway. However, it is still unclear whether this protein, and its bound PI, has a role in trafficking from the TGN to the endosomal compartment, or from the late endosomes to the TGN [57] .
Another protein that is able to interact with PI3P through its two FYVE domains is DFCP1 (double FYVE-containing protein 1) [58] . In contrast to the other FYVE-domaincontaining proteins described so far, DFCP1 has a distinct GC and ER localization. However, the association of this protein to the GC does not involve the binding of its FYVE domains to PI3P. As a result, the question of the role of PI3P at the GC remains to be clarified.
ARAP1 is a PI345P3-dependent Arf-GAP, and it has also a Rho-GAP activity. In addition to the Arf-GAP and Rho-GAP domains, it contains an ankyrin repeat, a Ras-associating (RA) domain, and five PH domains [59] . ARAP1 has been found to be associated with GC membranes, and it contains a PI3,4,5P3-dependent Arf-GAP activity that regulates the structure of the GC. The Rho-GAP domain of ARAP1 functions independently of the Arf-GAP domain in the induction of cell rounding and the loss of stress fibres [59] . Thus, ARAP1 might integrate PI, Arf, and Rho signalling at the GC, as well as at the plasma membrane.
The 4-phosphorylated polyphosphoinositides
PI4P has an important role at the GC that is independent of its use as precursor of the more phosphorylated PI species (e.g., PI4,5P2). In yeast, transport from the GC to the plasma membrane requires the activity of Pik1p (but not of the PIP5K, Msst4p), and Kes1p has been identified as one of the PI4P effectors at the GC [60] . As in yeast, in mammals, the PI4K activity is required for maintenance of the structural and functional organization of the GC. The overexpression of a catalytically inactive mutant of PI4KIIIh affects membrane transport from the GC to the plasma membrane and perturbs the structure of the GC [10] . Knocking down PI4KIIa with small interfering RNAs (siRNAs) causes fragmentation of the GC and inhibits membrane transport from the TGN to the plasma membrane and the endocytic compartment [61] .
Several TGN-associated proteins that bind PI4P have recently been identified (Fig. 2) . These include epsinR, an AP-1 accessory protein [62] , AP-1 itself [61] , FAPP1, FAPP2, and OSBP in unpolarized cells [63, 64] , and the Goodpasture antigen-binding protein (GPBP, also known as CERT; [65] ). These proteins operate in different transport steps: AP-1 and epsinR are involved in TGN-to-endosomes trafficking, and FAPPs, in the TGN-to-plasma membrane transport step. On the other hand, the role of GPBP/CERT in membrane trafficking has yet to be clarified, although it has been shown that it is responsible for the transfer of ceramide from the ER to the GC [65] .
AP-1 was initially thought to be the adaptor that is responsible for assembling clathrin-coated vesicles on the TGN for the transport of the M6PR and its bound lysosomal enzymes to the late endosomes/lysosomes. However, the M6PR was unexpectedly found to accumulate in endosomes and not in the TGN of fibroblasts from AP-1A knock-out mice [66] . Thus, AP-1 is now thought to function in both the anterograde and the retrograde transport steps between the TGN and endosomes and in traffic to the cell surface.
EpsinR binds PI4P through its ENTH domain and also associates with clathrin and AP-1 [61, 62] ). Like AP-1, epsinR has been localized to GC membranes and peripheral structures that are most likely endosomes. However, this localization of epsinR does not depend on the presence of AP-1. Recently, it has also been shown that epsinR is required for the retrograde sorting of endogenous (TGN46, M6PR300) and exogenous (shiga toxin) proteins from the endosomes to the TGN [67] .
FAPP1 and FAPP2 bind PI4P through their PH domain, and in addition, only FAPP2 contains a glycolipid-transferprotein-like domain. Both endogenous and recombinant FAPPs localize to the GC and, in particular, to the exit sites of the TGN, where transport carriers destined for the plasma membrane are formed. The association of FAPPs with these sites relies on their PH domain, which specifically binds PI4P and the small GTPase Arf [63] . Displacing or knocking-down FAPPs inhibits cargo transfer to the plasma membrane, indicating that FAPPs are essential components of a PI4P-and Arf-regulated machinery that controls the generation of constitutive post-Golgi carriers directed to the plasma membrane.
It is intriguing to note that OSBP1 and GPBP/CERT, two proteins that have PH domains specific for PI4P, bind to the GC, and that at least one, OSBP1, may also interact with Arf-GTP. As with FAPP2, they also possess a lipid-binding module: the oxysterol-binding motif and the START domain, respectively. Interestingly, it has recently been shown that GPBP/CERT is targeted to the GC in a PI4P-dependent manner, and that this mediates the intracellular trafficking of the ceramides. Thus, there might be a superfamily of TGN-associated proteins with a common regulatory mechanism based on PI4P and Arf, but with distinctive lipid-transfer and/or binding properties, which could selectively target them to separate TGN microdomains, thus generating carriers with different cargo contents and destinations.
While these full-length proteins that possess PI4P-specific PH domains localize mainly to the TGN, depending on the level of expression and the cell type, their isolated PH domains (that bear, however, an additional PI-independent and Arf-dependent GC-targeting signal, as discussed above) can be seen to localize also in other subcompartments of the GC or can also be found in extra-GC locations [63, 68, 69] . In fact, there are members of the OSBP family in yeast, such as Osh2p, that possess PI4P-specific PH domains that, possibly due to the lack of the additional Arf-dependent targeting signal, recognize PI4P pools at the plasma membrane [70] .
The 5-phosphorylated polyphosphoinositides
PI4,5P2 has been implicated in the control of ER-to-GC transport, in the formation of post-Golgi transport carriers, and in the maintenance of the GC structure [18, 71, 72] . This PI might thus exert these effects via the control of, for example, the spectrin-and dynamin-based machineries; the first of these is required in ER-to-Golgi transport, and the second in the release of transport carriers from the TGN. Alternatively, PI4,5P2 might function here by stimulating the activity of phospholipase D (PLD) and thus through control of the levels of PA in membranes. Despite the involvement of PI4,5P2 in different transport steps and the presence of PI4,5P2-binding proteins at the GC, at the fluorescence level, there is no obvious GC localization for the PI4,5P2-specific PH domain of phospholipase Cy (PLCy) tagged with GFP, which localizes instead mainly at the plasma membrane. However, by using the more sensitive approach of electron microscopy, Watt et al. [73] have indeed shown that PI45P2 is also present at the GC, with 25% in the tubulovesicular areas, and 75% in the stacks [73] .
Concluding remarks
Many different approaches have been undertaken to investigate the roles of the PIs. These have ranged from the knock-out of the enzyme activities by pharmacologically means or by dominant-negative mutants or siRNAs, the ''sequestering'' of PIs with drugs or PI-binding domains, and the direct interference with the localization/levels of the PI targets. By combining the results so far obtained from all of these studies, it appears that the Golgi-subcompartment where the PIs play a pivotal role is the TGN, at the crossroads between the endocytic and exocytic pathways. Here, PI-generating enzymes and PI-binding proteins regulate the sorting/transport of cargoes destined for the plasma membrane, the endosomes, and, in specialized cells, the secretory granules. In addition to their role in controlling basic processes in membrane traffic at the GC, the PIs are also emerging as key ''landmarks'' for orienting/directing the non-vesicular transport of lipids from the ER to the GC, and to specific Golgi subdomains [74] .
